Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor

NCT06944457 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Solid Tumor Cancer
Biomarkers

Interventions

DRUG: MPD-1

Sponsor

Pharosgen Co.,Ltd